LifeStance Health Group, Inc. - Laporan Laba Rugi (TTM)

LifeStance Health Group, Inc.
US ˙ NasdaqGS ˙ US53228F1012

Laporan Laba Rugi (TTM)

Laporan Laba Rugi LifeStance Health Group, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 377 447 524 596 668 727 776 820 860 909 959 1,004 1,056 1,104 1,156 1,206 1,251 1,284 1,316
Change (%) 18.56 17.11 13.72 12.07 8.98 6.73 5.63 4.80 5.76 5.51 4.73 5.10 4.53 4.78 4.31 3.72 2.60 2.57
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 243 284 333 381 466 523 571 615 623 657 694 723 754 776 804 830 849 866 888
Change (%) 16.91 17.24 14.51 22.24 12.17 9.22 7.81 1.14 5.48 5.62 4.24 4.24 3.02 3.60 3.18 2.26 2.06 2.58
% of Revenue 64.39 63.49 63.56 64.00 69.81 71.85 73.53 75.04 72.43 72.23 72.31 71.98 71.38 70.35 69.55 68.80 67.83 67.47 67.48
Gross Operating Profit 134 163 191 214 202 205 206 205 237 252 266 281 302 327 352 376 402 417 428
Change (%) 21.55 16.90 12.34 -6.01 1.62 0.39 -0.42 15.79 6.50 5.21 5.99 7.33 8.32 7.59 6.88 6.94 3.74 2.55
% of Revenue 35.61 36.51 36.44 36.00 30.19 28.15 26.47 24.96 27.57 27.77 27.69 28.02 28.62 29.65 30.45 31.20 32.17 32.53 32.52
SG&A 88 113 185 331 431 495 504 414 373 355 348 346 343 347 346 352 360 367 369
Change (%) 28.93 63.24 79.17 30.16 14.72 1.95 -17.83 -9.88 -4.89 -2.10 -0.35 -0.93 1.07 -0.21 1.62 2.41 1.73 0.72
% of Revenue 23.29 25.32 35.29 55.61 64.59 67.99 64.94 50.52 43.44 39.07 36.25 34.50 32.52 31.44 29.94 29.17 28.80 28.56 28.04
R&D
Change (%)
% of Revenue
OpEx 362 438 565 763 951 1,075 1,137 1,096 1,065 1,084 1,117 1,147 1,177 1,207 1,233 1,260 1,280 1,295 1,315
Change (%) 21.16 28.92 34.96 24.74 13.00 5.75 -3.62 -2.77 1.80 2.97 2.68 2.68 2.54 2.18 2.17 1.56 1.16 1.57
% of Revenue 95.91 98.01 107.88 128.03 142.51 147.76 146.39 133.57 123.92 119.29 116.42 114.15 111.52 109.39 106.67 104.48 102.31 100.88 99.90
Operating Income 15 9 -41 -167 -284 -347 -360 -275 -206 -175 -158 -142 -122 -104 -77 -54 -29 -11 1
Change (%) -42.21 -562.88 304.41 69.94 22.44 3.69 -23.57 -25.32 -14.72 -10.17 -9.77 -14.43 -14.77 -25.56 -29.95 -46.59 -61.06 -111.99
% of Revenue 4.09 1.99 -7.88 -28.03 -42.51 -47.76 -46.39 -33.57 -23.92 -19.29 -16.42 -14.15 -11.52 -9.39 -6.67 -4.48 -2.31 -0.88 0.10
Interest Expense -22 -29 -45 -42 -39 -34 -18 -18 -20 -22 -20 -21 -21 -22 -23 -23 -27 -24 -21
Change (%) 31.41 55.95 -6.43 -8.31 -13.34 -47.57 3.88 8.51 8.28 -9.33 6.58 1.76 3.82 3.20 -0.28 17.04 -10.67 -12.33
% of Revenue -5.87 -6.50 -8.66 -7.12 -5.83 -4.64 -2.28 -2.24 -2.32 -2.37 -2.04 -2.08 -2.01 -2.00 -1.97 -1.88 -2.12 -1.85 -1.58
Net Income -38 -49 -87 -205 -307 -361 -360 -277 -216 -187 -164 -188 -186 -173 -151 -95 -57 -36 -16
Change (%) 29.77 77.10 133.90 50.10 17.46 -0.36 -22.97 -22.16 -13.03 -12.40 14.45 -0.90 -7.06 -12.82 -36.86 -39.72 -37.96 -54.68
% of Revenue -10.09 -11.05 -16.70 -34.36 -46.02 -49.60 -46.31 -33.77 -25.08 -20.62 -17.12 -18.71 -17.64 -15.69 -13.05 -7.90 -4.59 -2.78 -1.23

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista